Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV) [Phase 1]

View source ↗

Summary

This completed Phase 1 study evaluated drug-drug interactions between BMS-663068 (fostemsavir) and etravirine and/or darunavir boosted with ritonavir in HIV inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-663068 (BMS-626529)
  • Intelence (Etravirine)
  • Norvir (ritonavir)
  • PREZISTA (darunavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED